creighton, now you know it's not similar, matter of fact the one and probably first indication that will be tested for this drug is for an unmet medical need(pool of 25k patients), followed by a 'me too' indication(75k patients) but with a potency many times better than the ones in the market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.